Paracetamol in Patent Ductus Arteriosus
A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 110 participants.
Also called NCT02422966
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 2
- Enrolled
- 110 participants
- Sponsor
- Aziende Chimiche Riunite Angelini Francesco S.p.A
- Registry
-
NCT02422966
-
- Other papers using this trial's data
- Intravenous paracetamol in comparison with ibuprofen for the treatment of patent ductus arteriosus in preterm infants: a randomized controlled trial
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- Italy
- Registry status
- Completed
Technical summary
Registry record NCT02422966. Randomized; no masking; primary purpose treatment. Start 2015-12 (actual); primary completion 2019-01 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Paracetamol in Patent Ductus Arteriosus
- Condition
- Ductus Arteriosus, Patent
- Intervention (Drug)
- Paracetamol
- Intervention (Drug)
- Ibuprofen
- Lead sponsor
- Aziende Chimiche Riunite Angelini Francesco S.p.A
Record details
- Record id
cardio:ct-nct02422966- Content hash
405b83ececcbfe5011b8469275fb1ef46cb360752deebfa30eb26c88aff95a64